Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-10
DOI
10.1007/s10549-020-05827-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy
- (2019) Tatyana Gorodnova et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons
- (2019) Eric R. Manahan et al. ANNALS OF SURGICAL ONCOLOGY
- The spectrum of mutations predisposing to familial breast cancer in Poland
- (2019) Cezary Cybulski et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
- (2019) Debora Mancini-DiNardo et al. BMC Medical Genomics
- BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study
- (2018) Artur Kowalik et al. PLoS One
- ATL
- (2018) Tatyana V. Gorodnova et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA mutation in ovarian cancer: testing, implications and treatment considerations
- (2017) Robert T. Neff et al. Therapeutic Advances in Medical Oncology
- Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review
- (2016) Kandice K. Ludwig et al. AMERICAN JOURNAL OF SURGERY
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer
- (2016) Karin Kast et al. JOURNAL OF MEDICAL GENETICS
- New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
- (2015) Anna Kluska et al. BMC Medical Genomics
- Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer
- (2015) Timothy R. Rebbeck et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
- (2014) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- BRCA1 founder mutations compared to ovarian cancer in Belarus
- (2014) Alena Savanevich et al. Familial Cancer
- Prevalence of the most frequent BRCA1 mutations in Polish population
- (2011) Izabela Brozek et al. JOURNAL OF APPLIED GENETICS
- Non-founder BRCA1 mutations in Russian breast cancer patients
- (2010) Aglaya G. Iyevleva et al. CANCER LETTERS
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
- (2010) Susan M. Domchek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started